NextStep Robotics receives NIH Phase II cooperative agreement
The NIH National Institute of Neurological Disorders and Stroke awarded NextStep Robotics Phase II support for a clinical trial of AMBLE.
Evidence notes
- The Fast-Track cooperative agreement was worth USD 5.5 million across the programme.
- Phase II supported a planned 120-person clinical trial testing AMBLE safety and efficacy in stroke survivors with foot drop.
- The University of Maryland Rehabilitation and Orthopaedic Institute was selected to conduct the trial.
Company context
NextStep Robotics develops personalised robotic therapy for people with foot drop following stroke or neurological injury. Its clinic-based system adapts assistance to patient movement and captures progress data during repetitive gait training.